Pregnancy-Related Adverse Events with Tyrosine Kinase Inhibitor Use in Chronic Myeloid Leukemia: A FAERS Pharmacovigilance Analysis (2001-2024)

Faisal MS et al. Clin Lymphoma Myeloma Leuk, February 2026

• Share
• Tweet
• Share
• Share